StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$97.81+1.01 (+1.04%)

Close on Nov 18, 2026Market cap $6.15BP/E –Yield –

Kodiak Sciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Kodiak Sciences's operating income for the twelve months ending Jun 30, 2026 was -$246.42M. For fiscal 2025 it was -$234.39M. The highest annual figure on record is -$17.15M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$234.39M–
FY2024Dec 31, 2024-$186.85M–
FY2023Dec 31, 2023-$277.32M–
FY2022Dec 31, 2022-$341.38M–
FY2021Dec 31, 2021-$267.05M–
FY2020Dec 31, 2020-$136.01M–
FY2019Dec 31, 2019-$49.19M–
FY2018Dec 31, 2018-$26.37M–
FY2017Dec 31, 2017-$25.52M–
FY2016Dec 31, 2016-$17.15M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$66.84M–
Q1 FY2026Mar 31, 2026-$59.78M–
Q4 FY2025Dec 31, 2025-$57.45M–
Q3 FY2025Sep 30, 2025-$62.35M–
Q2 FY2025Jun 30, 2025-$55.51M–
Q1 FY2025Mar 31, 2025-$59.07M–
Q4 FY2024Dec 31, 2024-$46.18M–
Q3 FY2024Sep 30, 2024-$46.63M–
Q2 FY2024Jun 30, 2024-$47.98M–
Q1 FY2024Mar 31, 2024-$46.06M–
Q4 FY2023Dec 31, 2023-$63.37M–
Q3 FY2023Sep 30, 2023-$54.50M–
Q2 FY2023Jun 30, 2023-$84.83M–
Q1 FY2023Mar 31, 2023-$74.62M–
Q4 FY2022Dec 31, 2022-$74.07M–
Q3 FY2022Sep 30, 2022-$79.48M–
Q2 FY2022Jun 30, 2022-$92.07M–
Q1 FY2022Mar 31, 2022-$95.77M–
Q4 FY2021Dec 31, 2021-$93.05M–
Q3 FY2021Sep 30, 2021-$67.54M–
Q2 FY2021Jun 30, 2021-$55.91M–
Q1 FY2021Mar 31, 2021-$50.56M–
Q4 FY2020Dec 31, 2020-$46.84M–
Q3 FY2020Sep 30, 2020-$36.66M–
Q2 FY2020Jun 30, 2020-$26.78M–
Q1 FY2020Mar 31, 2020-$25.72M–
Q4 FY2019Dec 31, 2019-$16.18M–
Q3 FY2019Sep 30, 2019-$12.73M–
Q2 FY2019Jun 30, 2019-$11.81M–
Q1 FY2019Mar 31, 2019-$8.46M–
Q4 FY2018Dec 31, 2018-$9.36M–
Q3 FY2018Sep 30, 2018-$6.38M–
Q2 FY2018Jun 30, 2018-$5.09M–
Q1 FY2018Mar 31, 2018-$5.55M–
Q4 FY2017Dec 31, 2017-$9.76M–
Q3 FY2017Sep 30, 2017-$3.98M–
Q2 FY2017Jun 30, 2017-$6.74M–
Q1 FY2017Mar 31, 2017-$5.04M–

More Kodiak Sciences figures

See a number that looks wrong?